Pharsight Monthly Summary
JANUARY, 2024
Recent happenings in patent protected drugs.
spacer_11
At a Glance
100
drug patents lapsed
Photos
61
new drug patents introduced
Reviews
spacer_11
Companies who recently launched drugs
 
 
ABBVIE
 
AGIOS PHARMS INC
 
ALCON LABS INC
 
ANTARES PHARMA INC
 
APELLIS PHARMS
 
ASTRAZENECA AB
 
AXSOME MALTA
 
BAUSCH
 
BEONE MEDICINES USA
 
BIOXCEL
 
CHIESI
 
EAGLE PHARMS
 
EYENOVIA
 
FAMYGEN LIFE SCI
 
GILEAD SCIENCES INC
 
HARM REDUCTION THERP
 
HERON THERAPS INC
 
JANSSEN PRODS
 
JAZZ PHARMS RES
 
LANTHEUS MEDCL
 
LNHC
 
MAYNE PHARMA
 
NORTON WATERFORD
 
PROGENICS PHARMS INC
 
RIGEL PHARMS
 
SEAGEN
 
SPRINGWORKS
 
STRIDES PHARMA INTL
 
 
spacer_11
Drugs not protected by their main patents
Drug Company
ABILIFY OTSUKA
ABILIFY MYCITE KIT OTSUKA
ADASUVE NOVA PNEUMA
ADDYI SPROUT PHARMS
ADLYXIN SANOFI-AVENTIS US
AGGRASTAT MEDICURE
ALDARA BAUSCH
ARNUITY ELLIPTA GLAXOSMITHKLINE
AURYXIA KERYX BIOPHARMS
AXUMIN BLUE EARTH
CLEVIPREX CHIESI
COPAXONE TEVA PHARMS USA
DALIRESP ASTRAZENECA
DEXILANT TAKEDA PHARMS USA
DEXILANT SOLUTAB TAKEDA PHARMS USA
ELELYSO PFIZER
EMEND MSD MERCK CO
EPIVIR VIIV HLTHCARE
FERAHEME COVIS
FLONASE SENSIMIST ALLERGY RELIEF HALEON US HOLDINGS
GADAVIST BAYER HLTHCARE
GILENYA NOVARTIS
GLEEVEC NOVARTIS
IQIRVO IPSEN
IRESSA ASTRAZENECA
JADENU SPRINKLE NOVARTIS
JUXTAPID CHIESI
LEVEMIR FLEXTOUCH NOVO NORDISK INC
LIPTRUZET ORGANON
LUMASON BRACCO
LYRICA CR UPJOHN
MACRILEN AETERNA ZENTARIS
MOVIPREP SALIX PHARMS
MYRBETRIQ GRANULES APGDI
NEXIUM 24HR ASTRAZENECA LP
NORDITROPIN FLEXPRO NOVO NORDISK INC
NOVOLOG FLEXTOUCH NOVO NORDISK INC
NOXAFIL MERCK SHARP DOHME
OMONTYS TAKEDA PHARMS USA
OMONTYS PRESERVATIVE FREE TAKEDA PHARMS USA
ORBACTIV MELINTA THERAP
PEPAXTO ONCOPEPTIDES AB
RAPIVAB BIOCRYST
REYATAZ BRISTOL MYERS SQUIBB
SAXENDA NOVO
SELZENTRY VIIV HLTHCARE
SOLIQUA 100/33 SANOFI-AVENTIS US
SOMAVERT PHARMACIA
SPIRIVA RESPIMAT BOEHRINGER INGELHEIM
SYNRIBO TEVA PHARMS INTL
TORISEL PF PRISM CV
TRUVADA GILEAD
VASCEPA AMARIN PHARMS
VELPHORO VIFOR FRESENIUS
VENLAFAXINE BESYLATE ALMATICA
VIIBRYD ABBVIE
VYVANSE TAKEDA PHARMS USA
XARELTO JANSSEN PHARMS
XEGLYZE HATCHTECH
XEPI LNHC
XTORO FONSECA BIOSCIENCES
ZYVOX PFIZER
Drug patents lapsed
Drug Patent Patent expiry
ALOXI 7947724 2024-01-30
ALOXI 7947725 2024-01-30
ALOXI 7960424 2024-01-30
ALOXI 8518981 2024-01-30
ALOXI 8598218 2024-01-30
ALOXI 8598219 2024-01-30
ALOXI 8729094 2024-01-30
ALOXI 9066980 2024-01-30
ALOXI 9125905 2024-01-30
ALOXI 9173942 2024-01-30
ALOXI 9439854 2024-01-30
ALOXI 9457020 2024-01-30
ALOXI 9457021 2024-01-30
ALOXI 7947724 2024-01-30
ALOXI 7947725 2024-01-30
ALOXI 7960424 2024-01-30
ALOXI 8518981 2024-01-30
ALOXI 8598218 2024-01-30
ALOXI 8598219 2024-01-30
ALOXI 9125905 2024-01-30
ALOXI 9173942 2024-01-30
ALOXI 9439854 2024-01-30
ALOXI 9457020 2024-01-30
ATRIPLA 8592397 2024-01-13
ATRIPLA 8716264 2024-01-13
ATRIPLA 9457036 2024-01-13
ATRIPLA 9744181 2024-01-13
COMPLERA 8592397 2024-01-13
COMPLERA 8716264 2024-01-13
COMPLERA 9457036 2024-01-13
COMPLERA 9744181 2024-01-13
DIFICID 8586551*PED 2024-01-15
DIFICID 8586551*PED 2024-01-15
EVOCLIN 7374747 2024-01-23
GIVLAARI 9708610 2024-01-01
HALAVEN 6214865*PED 2024-01-20
LANTUS 7476652*PED 2024-01-23
LAZANDA 8889176 2024-01-16
LAZANDA 9078814 2024-01-08
LAZANDA 9814705 2024-01-08
LAZANDA 8889176 2024-01-16
LAZANDA 9078814 2024-01-08
LAZANDA 9814705 2024-01-08
LAZANDA 9814705 2024-01-08
LEQVIO 9708610 2024-01-01
LINZESS 7371727 2024-01-28
LINZESS 7704947 2024-01-28
LINZESS 7745409 2024-01-28
LINZESS 8080526 2024-01-28
LINZESS 8110553 2024-01-28
LINZESS 7371727 2024-01-28
LINZESS 7704947 2024-01-28
LINZESS 7745409 2024-01-28
LINZESS 8080526 2024-01-28
LINZESS 8110553 2024-01-28
LINZESS 7371727 2024-01-28
LINZESS 7704947 2024-01-28
LINZESS 7745409 2024-01-28
LINZESS 8080526 2024-01-28
LINZESS 8110553 2024-01-28
NUPLAZID 10028944 2024-01-15
NUPLAZID 8618130 2024-01-15
NUPLAZID 8921393 2024-01-15
NUPLAZID 9566271 2024-01-15
NUPLAZID 10028944 2024-01-15
NUPLAZID 8618130 2024-01-15
NUPLAZID 8921393 2024-01-15
NUPLAZID 9566271 2024-01-15
NUPLAZID 10028944 2024-01-15
NUPLAZID 8618130 2024-01-15
NUPLAZID 8921393 2024-01-15
NUPLAZID 9566271 2024-01-15
OMIDRIA 8173707*PED 2024-01-30
OMIDRIA 8586633*PED 2024-01-30
OMIDRIA 9278101*PED 2024-01-30
OMIDRIA 9399040*PED 2024-01-30
PROLENSA 8669290 2024-01-16
PROLENSA 8754131 2024-01-16
PROLENSA 8871813 2024-01-16
PROLENSA 8927606 2024-01-16
PROLENSA 9144609 2024-01-16
PROLENSA 9561277 2024-01-16
RHOFADE 8815929 2024-01-22
SEASONIQUE 7320969 2024-01-30
STRIBILD 8592397 2024-01-13
STRIBILD 8716264 2024-01-13
STRIBILD 9457036 2024-01-13
STRIBILD 9744181 2024-01-13
TASIGNA 7169791*PED 2024-01-04
TASIGNA 7169791*PED 2024-01-04
TASIGNA 7169791*PED 2024-01-04
TOBI PODHALER 7516741 2024-01-11
TORISEL 8299116*PED 2024-01-25
TORISEL 8455539*PED 2024-01-25
TORISEL 8722700*PED 2024-01-25
TRUVADA 8592397 2024-01-13
TRUVADA 8716264 2024-01-13
TRUVADA 9457036 2024-01-13
TRUVADA 9744181 2024-01-13
ZAVZPRET 7220862 2024-01-21
Newly introduced Drug Patents
Drug Patent Patent expiry
ANNOVERA 11850251 2039-06-21
APONVIE 11878074 2035-09-18
BELRAPZO 11872214 2031-01-28
BENDEKA 11872214 2031-01-28
BIJUVA 11865179 2032-11-21
BRUKINSA 11851437 2037-08-15
DEFINITY 11857646 2037-03-16
DEFINITY RT 11857646 2037-03-16
EDURANT 7125879*PED 2025-10-21
EMPAVELI 11844841 2038-12-09
EPIDIOLEX 11865102 2039-04-26
EPSOLAY 11865100 2040-02-19
EYSUVIS 11872318 2033-05-03
GAVRETO 11872192 2039-04-03
IGALMI 11890272 2040-07-17
INVELTYS 11872318 2033-05-03
LYVISPAH 11850225 2041-09-29
MYCAPSSA 11857595 2036-02-03
MYDCOMBI 11839487 2031-07-15
OGSIVEO 11872211 2043-05-19
OGSIVEO 11884634 2039-08-09
OGSIVEO 11884635 2039-08-09
PYLARIFY 11851407 2037-06-09
PYRUKYND 11878049 2041-07-31
QVAR REDIHALER 11865247 2038-01-26
RIVIVE 11806428 2032-05-11
RYZUMVI 10278918 2034-01-31
RYZUMVI 10772829 2034-01-31
RYZUMVI 11090261 2034-01-31
RYZUMVI 11844858 2034-01-31
RYZUMVI 9795560 2034-01-31
SUNOSI 11857528 2040-03-19
SUNOSI 11872203 2042-12-30
SUNOSI 11872204 2042-12-30
TUKYSA 11666572 2038-04-27
UBRELVY 11857542 2041-12-22
VEKLURY 10065958*PED 2032-03-16
VEKLURY 10675296*PED 2039-01-10
VEKLURY 10695361*PED 2037-03-16
VEKLURY 11007208*PED 2037-03-16
VEKLURY 11266681*PED 2039-01-10
VEKLURY 11382926*PED 2037-03-16
VEKLURY 11491169*PED 2041-11-28
VEKLURY 11492353*PED 2032-06-08
VEKLURY 8008264*PED 2030-03-06
VEKLURY 8318682*PED 2029-10-22
VEKLURY 9724360*PED 2036-04-29
VEKLURY 9949994*PED 2036-04-29
VEKLURY RE46762*PED 2029-10-22
WAINUA (AUTOINJECTOR) 10683499 2034-08-25
WAINUA (AUTOINJECTOR) 8101743 2026-04-01
WAINUA (AUTOINJECTOR) 9127276 2034-05-01
WAINUA (AUTOINJECTOR) 9181549 2034-05-01
XYOSTED (AUTOINJECTOR) 11844804 2033-06-04
ZELSUVMI 10265334 2032-07-03
ZELSUVMI 10376538 2030-08-20
ZELSUVMI 11285098 2034-02-28
ZELSUVMI 8282967 2026-05-30
ZELSUVMI 8956658 2026-05-30
ZELSUVMI 9526738 2031-09-03
ZYCLARA 11850245 2030-04-30
What's new on Pharsight!

Find the answers you need on Drugs.

Are you looking for accurate and reliable information on drugs and generics? Look no further! Our FAQ page is packed with answers to some of the most commonly asked questions about drugs. Visit and bookmark our FAQ page today!

Bonus - Don't see your question answered there? Contact us, and we'll be happy to help!

Check out FAQ page

Shoot first, and win big! Figure out the drugs that are about to enter the NCE-1 period to stay ahead of your generic launch strategy!

Want to be first-to-market with your generic drugs? Stay ahead of the game with our exclusive list of drugs facing patent challenges updated every month.

Check out NCE-1 period list

spacer_11

Our insights are consumed by 1000+ leading pharma companies

© 2024 GreyB Research